Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome-Reference-Cited by-同舟云学术

Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome

Published:2017-07-17 Issue:6 Volume:55 Page:4745-4762
ISSN:0893-7648
Container-title:Molecular Neurobiology
language:en
Short-container-title:Mol Neurobiol

Author:

Vidal Verónica,García-Cerro Susana,Martínez Paula,Corrales Andrea,Lantigua Sara,Vidal Rebeca,Rueda Noemí,Ozmen Laurence,Hernández Maria-Clemencia,Martínez-Cué Carmen^ORCID

Funder

Ministerio de Economía y Competitividad

Fondation Jérôme Lejeune

Fundación Tatiana Pérez de Guzmán el Bueno

Publisher

Springer Science and Business Media LLC

Subject

Neuroscience (miscellaneous),Cellular and Molecular Neuroscience,Neurology

Link

http://link.springer.com/article/10.1007/s12035-017-0675-3/fulltext.html

Reference113 articles.

1. Lister RG (1985) The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev 9:87–94

2. Cole SO (1986) Effects of benzodiazepines on acquisition and performance: a critical assessment. Neurosci Biobehav Rev 10:265–272

3. Ghoneim MM, Mewaldt SP (1990) Benzodiazepines and human memory: a review. Anesthesiology 72:926–938

4. Jensen S, Kirkegaard L, Anderson BN (1987) Randomized clinical investigation of Ro 15-1788, a benzodiazepine antagonist, in reversing the central effects of flunitrazepam. Eur J Anaesthesiol 4:113–118

5. Venault P, Chapouthier G, Simiand J, Dodd RH, Rossier J (1987) Enhancement of performance by methyl beta-carboline-3-carboxylate, in learning and memory tasks. Brain Res Bull 19:365–370

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term α5 GABA A receptor negative allosteric modulator treatment reduces NMDAR-mediated neuronal excitation and maintains basal neuronal inhibition;Neuropharmacology;2023-10

2. Brain circuit pathology in Down syndrome: from neurons to neural networks;Reviews in the Neurosciences;2022-09-29

3. Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes;Pharmacology Biochemistry and Behavior;2022-06

4. Hyper-Rigid Phasic Organization of Hippocampal Activity But Normal Spatial Properties of CA1 Place Cells in the Ts65Dn Mouse Model of Down Syndrome;The Journal of Neuroscience;2022-01-03

5. Long-term voluntary running modifies the levels of proteins of the excitatory/inhibitory system and reduces reactive astrogliosis in the brain of Ts65Dn mouse model for Down syndrome;Brain Research;2021-09